Investor

2026-27

Title	File	Download
Intimation regarding Incorrect Event Display on NSDL Portal		Click Here

2025-26

Title	File	Download
Announcement Under Regulation 30 (LODR) - Updates 08.04.2025		Click Here
Announcment Under Regulation 30 (LODR)- Update 03.04.2025		Click Here
Approval Of Abbreviated New Drug Application (ANDA) 03.06.2025		Click Here
Change in management 1		Click Here
Change in management		Click Here
Change in management- 12.08.2025		Click Here
EU approval		Click Here
Observation(s) reported by Secretarial Auditor in Secretarial Compliance Report		Click Here

2024-25

Title	File	Download
Announcement Under Regulation 30 (LODR) - Updates 07.03.2025		Click Here
Announcement under Regulation 30 (LODR)-Change in Management		Click Here
Announcement Under Regulation 30 Of LODR		Click Here
Change Of Name Of (RTA) Of The Company		Click Here
Expansion Into Regulated Markets And Long Term Vision 28.03.2025		Click Here
MBL Has Been Awarded By Hon'ble Health Minister Of Ethiopia 27.02.2025		Click Here
Resignation of Chief Financial Officer (CFO)		Click Here
Updates (Manufacturing And Supply Agreement)		Click Here

2023-24

Title	File	Download
Announcement under Regulation 30 (LODR)-Acquisition		Click Here
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015		Click Here
Conversion of Securities 13.02.2024		Click Here
First ANDA in eCTD 19.07.2023		Click Here
Regulation 30 (LODR)-Acquisition		Click Here
SEBI (PIT) Regulations, 2015		Click Here
Trading Plan under SEBI (PIT) Regulations, 2015 02.032024		Click Here
Trading Plan under SEBI (PIT) Regulations, 2015 06.03.2024		Click Here
Trading Plan under SEBI (PIT) Regulations, 2015 08.03.2024		Click Here
Trading Plan under SEBI (PIT) Regulations, 2015 16.03.2024		Click Here
VALUE CREATOR by FOPE 12.06.2023		Click Here

2022-23

Title	File	Download
Announcement under Regulation 30 (LODR)-Acquisition 31.12.2021		Click Here
MBL had formed a subsidiary company 'Medicamen Life Sciences Private Limited'		Click Here
MBL has received GMP Compliance Certificate from (EFDA)		Click Here
Trading Plan under SEBI (PIT) Regulations, 2015		Click Here

2021-22

Title	File	Download
Acquisition 16.12.2021		Click Here
Acquisition 16.12.2021		Click Here
Announcement under Regulation 30 (LODR)-Acquisition 03.01.2022		Click Here
Announcement under Regulation 30 (LODR)-Acquisition 21.12.2021		Click Here
Announcement under Regulation 30 (LODR)-Acquisition 29.12.2021		Click Here
Regulation 30 (LODR)-Acquisition 16.12.2021		Click Here
Regulation 30 (LODR)-Acquisition 18.12.2021		Click Here
Regulation 30 (LODR)-Acquisition 21.12.2021		Click Here
Regulation 30 (LODR)-Trading Plan under SEBI (PIT) 16.12.2021		Click Here
Regulation 30 (LODR)-Updates on Acquisition		Click Here
Trading Plan under SEBI (PIT) 2021		Click Here
Trading Plan 21.12.2021		Click Here
Trading Plan under SEBI (PIT) 16.12.2021		Click Here
Trading Plan under SEBI (PIT) 18.12.2021		Click Here
Trading Plan under SEBI (PIT) 29.12.2021		Click Here
Trading Plan under SEBI (PIT) 31.12.2021		Click Here
Trading Plan under SEBI (PIT) 03.01.2022		Click Here

2020-21

Title	File	Download
Announcement Under Regulation 30 (LODR) - Upgradation Of Plant		Click Here
License To Manufacture		Click Here
Regulation 30 (LODR) Analyst Investor Meet 24.02.2021		Click Here
Trading Plan 21.12.2021		Click Here
Trading Plan under SEBI (PIT) 03.01.2022		Click Here

2019-20

Title	File	Download
Announcement under Regulation 30 (LODR)-Change in Directorate		Click Here
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015		Click Here
Announcement under Regulation 30 (LODR)-Resignation of Director		Click Here

2018-19

Title	File	Download
Announcement under Regulation 30 (LODR)-Change in Directorate		Click Here
Announcement under Regulation 30 (LODR)-Change in Directorate.		Click Here